|
Anebulo Pharmaceuticals Inc (ANEB) |
|
Anebulo Pharmaceuticals Inc
ANEB's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Anebulo Pharmaceuticals Inc 's sales fell
in IV. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 5.16 %
Anebulo Pharmaceuticals Inc net loss decreased from $-2 millions, to $-1 millions in IV. Quarter 2024,
• More on ANEB's Growth
|
|
Anebulo Pharmaceuticals Inc realized a net loss in trailing twelve months.
Anebulo Pharmaceuticals Inc realized cash reduction of $ -0.32 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.
• More on ANEB's Valuation
|
|
|
|
|
Anebulo Pharmaceuticals Inc realized net loss in trailing twelve months.
Anebulo Pharmaceuticals Inc realized cash outflow of $ -0.32per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.
Anebulo Pharmaceuticals Inc Price to Book Ratio is at 9.41 lower than Industry Avg. of 81.1. and higher than S&P 500 Avg. of 0.01
• More on ANEB's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com